Why spend borrowed money on the privilege to sell someone elses product for them?
Surely some form of commission based arrangement with a worthwhile rebate after reaching an agreed $ target would be serving shareholders interests in a fairer way
Seems dumb to me
And looks like US investors do as well!
Ann: AVITA Medical Expands Portfolio with Unique Dermal Matrix, page-26
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.60 |
Change
0.020(0.78%) |
Mkt cap ! $180.1M | |||
| Open | High | Low | Value | Volume |
| $2.59 | $2.63 | $2.56 | $229.1K | 88.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $2.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.60 | 18050 | 2 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| AVH (ASX) Chart |